Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph R Weichselbaum

Showing results (21-30 of 364) with videos related to

Pageof 37
Sort By:
RNA (New York, N.Y.)|December 24, 2024
<i>N</i> <sup>6</sup>-methyladenosine reader YTHDF2 in cell state transition and antitumor immunityLiangliang Wang, Ralph R Weichselbaum, Chuan He
Advanced Materials (Deerfield Beach, Fla.)|December 16, 2022
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor EfficacyWenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
Nature Clinical Practice. Gastroenterology & Hepatology|November 26, 2008
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?Ruchika Gutt, Stanley L Liauw, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2012
Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growthNikolai N Khodarev, Bernard Roizman, Ralph R Weichselbaum
Nature Reviews. Gastroenterology & Hepatology|July 15, 2010
The role of radiotherapy in locally advanced pancreatic carcinomaRuchika Gutt, Stanley L Liauw, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapyKimberly S Corbin, Samuel Hellman, Ralph R Weichselbaum
The Lancet. Oncology|August 1, 2024
Radiotherapy, immunity, and immune checkpoint inhibitorsConnor Lynch, Sean P Pitroda, Ralph R Weichselbaum
Science Immunology|December 27, 2016
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implicationsMichael Spiotto, Yang-Xin Fu, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite"Ainhoa Arina, Stanley I Gutiontov, Ralph R Weichselbaum
JAMA Oncology|January 6, 2022
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget RadiotherapyJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Pageof 37

Showing results (21-30 of 364) with videos related to

Sort By:
Pageof 37
RNA (New York, N.Y.)|December 24, 2024
<i>N</i> <sup>6</sup>-methyladenosine reader YTHDF2 in cell state transition and antitumor immunityLiangliang Wang, Ralph R Weichselbaum, Chuan He
Advanced Materials (Deerfield Beach, Fla.)|December 16, 2022
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor EfficacyWenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
Nature Clinical Practice. Gastroenterology & Hepatology|November 26, 2008
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials?Ruchika Gutt, Stanley L Liauw, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2012
Molecular pathways: interferon/stat1 pathway: role in the tumor resistance to genotoxic stress and aggressive growthNikolai N Khodarev, Bernard Roizman, Ralph R Weichselbaum
Nature Reviews. Gastroenterology & Hepatology|July 15, 2010
The role of radiotherapy in locally advanced pancreatic carcinomaRuchika Gutt, Stanley L Liauw, Ralph R Weichselbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapyKimberly S Corbin, Samuel Hellman, Ralph R Weichselbaum
The Lancet. Oncology|August 1, 2024
Radiotherapy, immunity, and immune checkpoint inhibitorsConnor Lynch, Sean P Pitroda, Ralph R Weichselbaum
Science Immunology|December 27, 2016
The intersection of radiotherapy and immunotherapy: mechanisms and clinical implicationsMichael Spiotto, Yang-Xin Fu, Ralph R Weichselbaum
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Radiotherapy and Immunotherapy for Cancer: From "Systemic" to "Multisite"Ainhoa Arina, Stanley I Gutiontov, Ralph R Weichselbaum
JAMA Oncology|January 6, 2022
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget RadiotherapyJoe Y Chang, Vivek Verma, Ralph R Weichselbaum
Pageof 37